Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-21-001067
Filing Date
2021-04-02
Accepted
2021-04-02 11:19:34
Documents
2
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 4276
2 EX-24 DOCUMENT svennilson_poa.txt EX-24 3204
  Complete submission text file 0001593968-21-001067.txt   8922
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address
Svennilson Peter (Reporting) CIK: 0001606074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 21800937

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations